文献速递临床免疫临床生化

重度心衰患者血浆中O-糖基化内源性NT-proBNP的分子复杂性

Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
PubMed 文献 · Clin Chem · 2016-11-08

该研究用串联免疫亲和纯化、外糖苷酶处理、β-消除/Michael加成及高分辨纳流液相色谱-电喷雾多级质谱,在重度心衰患者(NT-proBNP>10000 ng/L)血浆中鉴定出循环(NT-)proBNP的9个糖基化位点,并发现每个鉴定到的蛋白水解糖肽均存在非糖基化形式。

要点

  • 重度心衰患者循环(NT-)proBNP存在9个不同糖基化位点。
  • 每个鉴定到的蛋白水解糖肽均同时检出非糖基化形式。
  • 商业免疫法抗体多针对中心区,主要检测非糖基化形式。

核心结论

  • 首次通过质谱分析直接证明重度心衰患者循环(NT-)proBNP存在复杂的内源性糖型分布,并鉴定出9个糖基化位点。
  • 该信息可能影响针对(NT-)proBNP中心区的商业免疫法,因其主要检测非糖基化形式。

研究设计与样本

  • 研究类型:对重度心衰患者肝素化血浆样本残余物进行糖基化位点表征分析。
  • 样本条件:重度心衰患者,NT-proBNP>10000 ng/L。
  • 方法:串联免疫亲和纯化、序贯外糖苷酶处理进行聚糖修剪、β-消除与Michael加成化学、高分辨纳流液相色谱电喷雾多级质谱。

主要发现

  • 在循环(NT-)proBNP上鉴定出9个不同糖基化位点。
  • 基于高精度质量测定和多级质谱检测到差异糖基化变体。
  • 每个鉴定到的蛋白水解糖肽均同时可检出非糖基化形式。

临床怎么用

  • 提示商业NT-proBNP/BNP免疫法因抗体多针对中心区、主要检测非糖基化形式,可能受糖基化影响。
  • 为理解循环中天然存在的(NT-)proBNP不同形式提供了糖基化位点信息。

局限性

  • 样本来自重度心衰患者肝素化血浆残余物,NT-proBNP>10000 ng/L,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently, N-terminal pro-B-type natriuretic peptide (NT-proBNP) and its physiologically active counterpart, BNP, are most frequently used as biomarkers for diagnosis, prognosis, and disease monitoring of heart failure (HF). Commercial NT-proBNP and BNP immunoassays cross-react to varying degrees with unprocessed proBNP, which is also found in the circulation. ProBNP processing and immunoassay response are related to O-linked glycosylation of NT-proBNP and proBNP. There is a clear and urgent need to identify the glycosylation sites in the endogenously circulating peptides requested by the community to gain further insights into the different naturally occurring forms. METHODS: The glycosylation sites of (NT-) proBNP (NT-proBNP and/or proBNP) were characterized in leftovers of heparinized plasma samples of severe HF patients (NT-proBNP: >10000 ng/L) by using tandem immunoaffinity purification, sequential exoglycosidase treatment for glycan trimming, β-elimination and Michael addition chemistry, as well as high-resolution nano-flow liquid chromatography electrospray multistage mass spectrometry. RESULTS: We describe 9 distinct glycosylation sites on circulating (NT-) proBNP in HF patients. Differentially glycosylated variants were detected based on highly accurate mass determination and multistage mass spectrometry. Remarkably, for each of the identified proteolytic glycopeptides, a nonglycosylated form also was detectable. CONCLUSIONS: Our results directly demonstrate for the first time a rather complex distribution of the endogenously circulating glycoforms by mass spectrometric analysis in HF patients, and show 9 glycosites in human (NT-) proBNP. This information may also have an impact on commercial immunoassays applying antibodies specific for the central region of (NT-) proBNP, which detect mostly nonglycosylated forms.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Halfinger B, Hammerer-Lercher A, Amplatz B, et al. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure. Clin Chem. 2016. PMID: 28062629. doi:10.1373/clinchem.2016.265397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。